EP 4196150 A1 20230621 - ANTI-CD72 CHIMERIC RECEPTORS AND USES THEREOF
Title (en)
ANTI-CD72 CHIMERIC RECEPTORS AND USES THEREOF
Title (de)
CHIMÄRE ANTI-CD72-REZEPTOREN UND VERWENDUNGEN DAVON
Title (fr)
RÉCEPTEURS CHIMÉRIQUES ANTI-CD72 ET UTILISATIONS DE CEUX-CI
Publication
Application
Priority
- US 202063066149 P 20200814
- US 202163172057 P 20210407
- US 202163226736 P 20210728
- US 2021046043 W 20210813
Abstract (en)
[origin: CA3189482A1] The present disclosure relates to compositions and methods comprising anti-CD72 chimeric antigen receptors, host cells modified to include anti-CD72 chimeric antigen receptor molecules. The provided compositions, methods, and uses include those for combination therapies involving administration of a chimeric engulfment receptor or chimeric Tim receptor, such as immune cells engineered to co-express both the anti-CD72 chimeric antigen receptor and the chimeric engulfment receptor or chimeric Tim receptor.
IPC 8 full level
A61K 39/00 (2006.01); A61P 35/02 (2006.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61K 39/001129 (2018.07); A61P 35/02 (2017.12); C07K 14/70503 (2013.01); C07K 14/7051 (2013.01); C07K 14/70521 (2013.01); C07K 14/70596 (2013.01); C07K 14/71 (2013.01); C07K 16/2851 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/585 (2013.01); A61K 2039/804 (2018.07); C07K 2317/622 (2013.01); C07K 2319/03 (2013.01); C07K 2319/92 (2013.01); C12N 2840/20 (2013.01)
Citation (search report)
See references of WO 2022036287A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
CA 3189482 A 20210813; EP 21777885 A 20210813